LEP and type 1 diabetes mellitus: Administration of WJ-MSCs alone or in combination with insulin ameliorated the signs of experimental T1D by enhancing the leptin signaling in the hypothalamus and consequently affecting the neuropeptide Y (NPY)/AgRP axis and the melanocortin-dependent mechanism in the brain [81].